国产细胞程序性死亡受体1抑制剂卡瑞利珠单抗联合阿帕替尼一线治疗中晚期原发性肝癌的疗效研究
徐金发, 宋文灿, 郑中显, 鲍瑜, 华高艳, 蔡清, 侍伟伟, 章秀芳, 张建华, 童舟, 夏国安, 刘飞, 刘林涛, 肖克胜
Efficacy of China-produced Camrelizumab with Apatinib for First-line Treatment in Middle and Advanced Stages of Primary Liver Cancer
Jinfa XU, Wencan SONG, Zhongxian ZHENG, Yu BAO, Gaoyan HUA, Qing CAI, Weiwei SHI, Xiufang ZHANG, Jianhua ZHANG, Zhou TONG, Guoan XIA, Fei LIU, Lintao LIU, Kesheng XIAO
中国全科医学
.
2022, (26): 3258
-3262
.
DOI: 10.12114/j.issn.1007-9572.2022.0208
